IL10 and melanoma: This may imply that cutAEs in melanoma, which induce an IL-10 response, should be treated fast and effectively to reduce cutAEs early and prevent further production of IL-10, as prolonged treatment with corticosteroids has been shown to blunt antitumor efficacy [45].